Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do molecular markers predict survival in non-small-cell lung cancer?

American journal of respiratory and critical care medicine - 1 Apr 1998

Greatens T M, Niehans G A, Rubins J B, Jessurun J, Kratzke R A, Maddaus M A, Niewoehner D E

Abstract excerpt

Patients with non-small-cell lung cancer (NSCLC) survive for variable lengths of time, even when adjustment is made for pathological stage. Numerous reports suggest that biological markers predict survival in patients undergoing surgery for NSCLC with curative intent, but many of these claims are unconfirmed or conflicting. We postulated that the use of multiple putative markers might provide greater power in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Genes, ras

Share to Genetic Markers

Share to Mutation

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9563724
DOI: 10.1164/ajrccm.157.4.9707108

Genes

MIA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do molecular markers predict survival in non-small-cell lung cancer?PMID 9563724Read ↗

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.Semantic proximity Read ↗

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Semantic proximity Read ↗

K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.Semantic proximity Read ↗

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.Semantic proximity Read ↗

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.Semantic proximity Read ↗

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.Semantic proximity Read ↗

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.Semantic proximity Read ↗

Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer.Semantic proximity Read ↗

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.Semantic proximity Read ↗

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.Semantic proximity Read ↗

Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.Semantic proximity Read ↗

Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.